# Function Oncology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/function-oncology

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.functiononcology.com
- Total disclosed funding: $28M
- Latest round: Series A (Apr 12, 2023)
- Investors on record: 4

## About

Based in California, US, and founded in 2023, Function Oncology, Inc. provides a platform to measure gene function and identifies valuable therapeutic opportunities. As of 2023, the company is headed by its CEO Srinath Sampath. In April 2023, the firm raised USD 28 million in Series A funding co-led by investors Andreessen Horowitz and Section 32, with participation from other investors Alexandria Venture Investments and Casdin Capital.

The company offers a platform for primary cell CRISPR profiling as well as personalized medicine based on functional genomics. Additionally, the firm identifies valuable therapeutic opportunities for patients and also develops the next generation of cancer therapies. 

The company plan to use the April 2023 funding to identify optimal therapeutic opportunities for cancer patients and develop new targeted treatments.

## Funding rounds

- Series A, Apr 12, 2023, $28M — Alexandria Venture Investments, Andreessen Horowitz, Casdin Capital, Section 32

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series A
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series A